| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 213 | 187 | 251 | 207 | 193 | 202 | 212 | 204 | 216 | 234 | 235 | 229 | 256 | 243 | 255 | 328 | 288 | 318 | 321 | 315 | 316 | 297 | 295 | 987 | 44 | 25 | 141 | 359 | 167 |
| Expenses | 155 | 136 | 163 | 157 | 148 | 163 | 165 | 156 | 167 | 179 | 178 | 185 | 199 | 180 | 194 | 270 | 227 | 252 | 259 | 267 | 250 | 224 | 236 | 437 | 43 | 24 | 132 | 147 | 149 |
| EBITDA | 58 | 51 | 88 | 50 | 46 | 40 | 47 | 48 | 49 | 55 | 57 | 44 | 57 | 63 | 61 | 58 | 60 | 66 | 62 | 47 | 66 | 73 | 59 | 549 | 1 | 1 | 9 | 211 | 18 |
| Operating Profit % | 16 % | 19 % | 18 % | 19 % | 21 % | 15 % | 19 % | 19 % | 21 % | 22 % | 21 % | 18 % | 21 % | 24 % | 21 % | 12 % | 19 % | 19 % | 17 % | 12 % | 19 % | 23 % | 18 % | 17 % | -29 % | -99 % | -6 % | -7 % | 2 % |
| Depreciation | 25 | 26 | 25 | 28 | 23 | 23 | 23 | 22 | 20 | 20 | 20 | 28 | 14 | 14 | 21 | 82 | 16 | 16 | 15 | 9 | 14 | 13 | 14 | 20 | 0 | 0 | 6 | 7 | 7 |
| Interest | 5 | 23 | 22 | 27 | 28 | 29 | 29 | 21 | 25 | 25 | 26 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 22 | 22 | 20 | 21 | 21 | 3 | 0 | 0 | 10 | -27 | 1 |
| Profit Before Tax | 28 | 3 | 40 | -5 | -6 | -12 | -5 | 4 | 5 | 10 | 12 | -8 | 19 | 25 | 16 | -47 | 20 | 26 | 24 | 16 | 32 | 39 | 24 | 527 | 1 | 1 | -7 | 231 | 10 |
| Tax | 0 | 0 | 0 | 20 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 21 | 0 | 1 | -0 | 14 | 0 | 1 | -3 | 41 | 14 | 7 | 5 | 33 | 0 | 0 | -1 | 8 | 2 |
| Net Profit | 28 | 3 | 40 | -25 | -6 | -12 | -5 | 3 | 5 | 10 | 12 | -29 | 19 | 25 | 16 | -62 | 20 | 25 | 28 | -25 | 17 | 32 | 19 | 494 | 1 | 0 | -6 | 222 | 9 |
| EPS in ₹ | 6.21 | 0.72 | 8.67 | -5.21 | -2.91 | -2.57 | -0.98 | 0.60 | 0.77 | 1.68 | 1.95 | -4.94 | 3.18 | 4.14 | 2.71 | -10.40 | 3.36 | 4.29 | 4.65 | -4.25 | 2.92 | 5.36 | 3.29 | 83.55 | 0.16 | 0.07 | -0.82 | 32.96 | 1.28 |
Ind Swift Laboratories
Ind Swift Laboratories
104.21
+3.61
(3.59%)
Key Fundamentals
Market Cap
765.80 Cr
EPS
37.25
PE Ratio
3.38
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
124.00
52 Week Low
68.72
PB Ratio
0.61
Debt to Equity
0.11
Sector
Pharmaceuticals Actual
Company News
View All News
Ind-Swift Laboratories Limited has received listing approval from the National Stock Exchange of India (NSE) on October 10, 2025, for equity shares allotted to eligible shareholders of Ind-Swift Limited under an approved scheme of amalgamation. The company filed listing applications with both NSE and BSE on September 12, 2025. While NSE approval has been granted, BSE approval is currently pending and expected shortly. Once BSE approval is received, the company will proceed with crediting shares to shareholders' Demat accounts and apply for trading approval. Shareholders will be able to trade the newly allotted equity shares only after trading approval is granted.
IND-SWIFT LABORATORIES Forms 50:50 Joint Venture for Chandigarh Premier League Cricket Team
Sep 12, 2025
Sep 12, 2025IND-SWIFT LABORATORIES LTD's investment committee approved the incorporation of a 50:50 joint venture with Mr. Nikhil Goel to participate in the first edition of the Chandigarh Premier League organized by the Union Territory Cricket Association. The joint venture will be structured as a Limited Liability Partnership (LLP) with the company contributing up to Rs. 2 crores. The venture's activities will include sponsorship/ownership of a cricket team in the CPL and participation in cricket tournaments and other sports-related initiatives. The company cited cricket's significant fan following and commercial potential in India, along with the strategic opportunity of associating with the CPL at its inception stage to build presence in the sports and entertainment ecosystem. The incorporation is subject to completion of statutory and regulatory formalities, and the investment does not constitute a related party transaction.
Ind-Swift Laboratories Limited's promoter and promoter group members acquired 39,46,094 equity shares valued over INR 10 lacs on August 25, 2025. The acquisition occurred through a scheme of arrangement for amalgamation between Ind-Swift Limited and Ind-Swift Laboratories Limited, approved by the National Company Law Tribunal, Chandigarh Bench on July 17, 2025. Six entities participated in the acquisition: S.R. Mehta (3,05,380 shares), Sunita Jain (2,71,860 shares), V.R. Mehta (2,88,204 shares), Neera Mehta (2,32,057 shares), Gopal Munjal (2,93,579 shares), and Essix Biosciences Limited (25,55,014 shares). The company submitted the required disclosure under SEBI insider trading regulations on August 27, 2025.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,697.80 | #1 4,07,359.10 | 38.84 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 57.82 | |
6,691.50 | 1,77,638.30 | 71.49 | 9,712.00 | 18.67 | 2,191 | 35.10 | 59.81 | |
3,817.50 | 1,29,201.50 | 60.37 | 11,539.40 | 6.99 | 1,911 | 30.46 | 70.23 | |
1,511.50 | 1,22,092.00 | 22.50 | 28,409.50 | 7.12 | 5,291 | 3.71 | 42.33 | |
1,198.70 | 1,00,045.20 | #1 17.43 | 33,741.20 | 16.73 | 5,725 | -0.38 | 35.45 | |
948.40 | 95,431.20 | 18.95 | 23,511.00 | 18.55 | 4,615 | 34.60 | 35.94 | |
2,236.60 | 92,317.60 | 52.03 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 23.38 | |
1,990.20 | 90,903.30 | 20.88 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 56.75 | |
5,679.50 | 67,906.90 | 29.10 | 13,458.30 | 3.70 | 2,216 | 21.39 | 64.68 | |
1,154.80 | 67,071.00 | 19.75 | 32,345.60 | 9.43 | 3,484 | 3.81 | 61.48 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
86.38 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 2,244 | 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,460 | 1,438 |
| Fixed Assets | 1,117 | 1,099 | 1,042 | 934 | 914 | 843 | 753 | 630 | 588 | 192 | 273 |
| Current Assets | 924 | 926 | 832 | 842 | 836 | 863 | 944 | 1,075 | 1,165 | 960 | 865 |
| Capital Work in Progress | 113 | 79 | 70 | 69 | 20 | 12 | 19 | 10 | 8 | 51 | 0 |
| Investments | 0 | 0 | 18 | 18 | 19 | 18 | 36 | 29 | 30 | 112 | 214 |
| Other Assets | 1,014 | 1,037 | 1,007 | 1,002 | 972 | 998 | 1,011 | 1,131 | 1,199 | 1,106 | 952 |
| Total Liabilities | 2,244 | 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,460 | 1,438 |
| Current Liabilities | 648 | 951 | 1,005 | 936 | 356 | 323 | 315 | 335 | 371 | 433 | 221 |
| Non Current Liabilities | 989 | 746 | 601 | 534 | 980 | 906 | 901 | 866 | 771 | 215 | 45 |
| Total Equity | 606 | 517 | 531 | 553 | 588 | 641 | 603 | 601 | 682 | 812 | 1,173 |
| Reserve & Surplus | 553 | 476 | 486 | 507 | 540 | 581 | 544 | 541 | 622 | 745 | 1,030 |
| Share Capital | 41 | 42 | 46 | 46 | 48 | 60 | 60 | 60 | 60 | 67 | 69 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 3 | -4 | -6 | 23 | -17 | 1 | 14 | -4 | 443 | -67 |
| Investing Activities | -35 | -29 | -31 | -17 | -13 | -9 | -10 | 5 | -13 | -28 | -110 |
| Operating Activities | 98 | 79 | 96 | 73 | -64 | 125 | 135 | 150 | 195 | -187 | -26 |
| Financing Activities | -64 | -48 | -69 | -62 | 100 | -133 | -124 | -141 | -186 | 657 | 69 |
Share Holding
| % Holding | Jan 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Aug 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sept 2025 |
| Promoter | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 42.00 % | 40.94 % | 40.94 % | 36.77 % | 39.50 % | 39.50 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.17 % | 0.00 % | 0.25 % | 1.26 % | 0.85 % | 0.65 % | 0.46 % | 3.07 % | 4.27 % | 0.00 % | 0.00 % | 14.80 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 19.49 % | 19.49 % | 19.49 % | 19.49 % | 19.49 % | 0.00 % | 8.03 % | 0.94 % | 0.94 % | 0.94 % | 0.94 % | 0.91 % | 0.91 % | 0.00 % | 0.00 % | 0.68 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 26.38 % | 27.72 % | 26.78 % | 29.03 % | 29.21 % | 29.31 % | 29.55 % | 29.06 % | 28.97 % | 29.08 % | 29.20 % | 28.77 % | 29.26 % | 30.46 % | 36.69 % | 36.80 % | 36.63 % | 38.11 % | 37.61 % | 41.36 % | 35.11 % | 34.75 % | 34.96 % |
| Others | 31.62 % | 30.28 % | 31.22 % | 28.98 % | 28.80 % | 28.68 % | 28.44 % | 9.44 % | 9.54 % | 9.43 % | 9.30 % | 9.56 % | 28.73 % | 19.26 % | 19.11 % | 19.41 % | 19.78 % | 18.49 % | 17.46 % | 12.51 % | 28.12 % | 25.76 % | 10.06 % |
| No of Share Holders | 14,525 | 15,859 | 21,466 | 25,225 | 24,528 | 25,342 | 24,910 | 24,226 | 24,456 | 23,397 | 22,962 | 25,405 | 24,633 | 22,439 | 25,461 | 29,536 | 28,883 | 28,752 | 28,190 | 28,709 | 28,539 | 28,892 | 43,780 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 14 Nov 2025 |  Quarterly Result Announcement | NA | 14 Nov 2025 | 100.95 | 100.65 |
| 06 Oct 2023 |  Extraordinary General Meeting | NA | 06 Oct 2023 | 102.85 | 89.69 |
| 22 Jul 2024 | Extraordinary General Meeting | NA | 22 Jul 2024 | 127.65 | 130.35 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 149.05 | 131.75 |
| 11 Nov 2024 | Quarterly Result Announcement | NA | 11 Nov 2024 | 115.20 | 112.50 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 103.70 | 91.90 |
| 22 Feb 2025 | Extraordinary General Meeting | NA | 22 Feb 2025 | 106.65 | 93.80 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 73.68 | 79.52 |
| 11 Aug 2025 | Quarterly Result Announcement | NA | 11 Aug 2025 | 104.60 | 99.80 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 106.67 | 104.95 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 97.98 | 99.93 |
Announcements
Board Meeting Intimation for Meeting To Be Held On 14/11/20253 days ago
3 days agoUPDATE ON LISTING OF SHARES ALLOTTED PURSUANT TO THE SCHEME OF AMALGAMATION6 days ago
6 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 29, 2025
Sep 29, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Intimation Regarding Outcome Of The Meeting Of Investment Committee Of The Board.Sep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 11, 2025
Sep 11, 2025Disclosure Under Regulation 10(6)- Report To Stock Exchanges In Respect Of Acquisition Made In Reliance Upon Exemption Provided For In Regulation 10 Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For Inter-Se Transfer Of SharesSep 10, 2025
Sep 10, 2025Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Sep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 07, 2025
Sep 07, 2025Notice Of The 30Th Annual General Meeting Of The Company For The Financial Year 2024-25.Sep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Sep 03, 2025Intimation Of Book Closure Pursuant To Regulation 42 Of SEBI (LODR) Regulations 2015Sep 01, 2025
Sep 01, 2025INTIMATION OF THE 30TH ANNUAL GENERAL MEETING E-VOTING AND BOOK CLOSURE FOR THE FINANCIAL YEAR 2024-25.Sep 01, 2025
Sep 01, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 30, 2025
Aug 30, 2025Disclosure Under Regulation 7(2)(B) Of Securities Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (SEBI (PIT) Regulations 2015)Aug 28, 2025
Aug 28, 2025Disclosure Pursuant To Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-AllotmentAug 25, 2025
Aug 25, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On August 25 2025Aug 25, 2025
Aug 25, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 14, 2025
Aug 14, 2025Standalone And Consolidated Un-Audited Financial Results Of Ind-Swift Laboratories Limited For The Quarter Ended 30Th June 2025Aug 13, 2025
Aug 13, 2025Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 13TH AUGUST 2025Aug 13, 2025
Aug 13, 2025Results-Delay in Financial ResultsAug 11, 2025
Aug 11, 2025Board Meeting Outcome for Outcome Of Board Meeting Dated August 11 2025Aug 11, 2025
Aug 11, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementAug 08, 2025
Aug 08, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 04, 2025
Aug 04, 2025Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Un-Audited Financial Results Of The Company For The Quarter Ended June 30 2025.Aug 02, 2025
Aug 02, 2025Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Financial Year Ended March 31 2025.Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJul 28, 2025
Jul 28, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 25, 2025
Jul 25, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jul 25, 2025
Jul 25, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 25, 2025
Jul 25, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 25, 2025
Jul 25, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesJul 22, 2025
Jul 22, 2025Announcement under Regulation 30 (LODR)-Scheme of ArrangementJul 17, 2025
Jul 17, 2025Intimation Regarding Re-Constitution Of Various Committees Of The Board Of The CompanyJul 04, 2025
Jul 04, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 04, 2025
Jul 04, 2025Disclosure Under Regulation 7(2) Read With Regulation 6(2) Of The SEBI (Prohibition Of Insider Trading) Regulations 2015Jul 04, 2025
Jul 04, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Jul 04, 2025Disclosure Under Regulation 29(1) Of The SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011Jul 04, 2025
Jul 04, 2025Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Jul 04, 2025
Jul 04, 2025Announcement under Regulation 30 (LODR)-Conversion of SecuritiesJul 02, 2025
Jul 02, 2025Closure of Trading WindowJun 30, 2025
Jun 30, 2025Intimation To Furnish Valid PAN KYC Details And Nomination By Shareholders Holding Physical Shares.Jun 21, 2025
Jun 21, 2025Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Jun 18, 2025
Jun 18, 2025Technical Indicators
RSI(14)
Neutral 44.12
ATR(14)
Less Volatile 3.45
STOCH(9,6)
Neutral 23.26
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.32
ADX(14)
Weak Trend 9.53
UO(9)
Bearish 34.97
ROC(12)
Downtrend And Accelerating -4.03
WillR(14)
Oversold -85.27
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
